HEDONE USA supplies the Left Atrial Appendage (LAA) Occluder, a minimally invasive device used to reduce the risk of stroke in patients with atrial fibrillation. The occluder effectively seals off the left atrial appendage, preventing blood clots from forming and entering the bloodstream, offering an alternative to long-term anticoagulant therapy.
This device offers a safe, effective solution for reducing stroke risk in atrial fibrillation patients.